Upfront Chromatography Appoints New CEO

Upfront Chromatography Appoints New CEO

 

Nov 18th 2013 -- "We'll set a new set of rules for the dairy industry" says CEO Michael Pålsson. After three years as the chairman of the board for Upfront is Michael Pålsson now the new CEO for the company. Upfront Chromatography will focus on food industry where company's technology already has demonstrated its value. With Mr Pålsson has Upfront Chromatography got a CEO with years of experience of successfully bringing new technologies to the industry by challenging the existing market and creating new settings.

Upfront Chromatography is the leading global provider of industrial scale chromatographic extraction technology. The company is located in Copenhagen, Denmark and operates around the world mainly with the food processing industry. Upfront's technology is already used globally at commercial-scale for the production of food enzymes, protein ingredients and bioactive components.

Protein components from the dairy-industry, soluble proteins from plants and industrial enzymes are the selected areas for Upfront to concentrate. According to Michael Pålsson it's especially the dairy industry that will benefit greatly from the technology. "We have already demonstrated our strength in the dairy industry globally and will proceed with our focus. Upfront's technology makes it possible for the right parties to create a new set of rules in the dairy industry. Our technology enables the production of highly valued ingredients to be produced more economically and in much larger scale than currently, any part of the world."

Michael Pålsson is technical engineer from the Danish Technical University (DTU). He has been CEO and director for a range of biotech and technology companies and is member and a chairman in several boards. Mr Pålsson will focus on transferring Upfront Chromatography into a significant actor in the global protein extraction and isolation technology. In the coming period of time will Upfront be recreated both with respect to the industry focus and the speed of action. Upfront Chromatography will be challenging the existing market and creating new settings for the industry.

For more information and for an interview with Michael Pålsson please contact Upfront Chromatography A/S Tel: +45 39 27 37 63 or Email to Mr Sami Sassi [email protected] 

Suggested Articles

With a new research team, outlook and more than a little help from the tech world, GSK has been quietly going about shoring up its pipeline.

The World Health Organization has called out Big Pharma for its dearth of antibiotic innovation amid a growing threat of antimicrobial resistance.

The trial hit its primary endpoint by the time of an interim analysis, enabling Chi-Med to stop the study and start work on a filing for approval.